We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Metabolism-Based Blood Test Predicts COVID-19 Severity and Risk

By LabMedica International staff writers
Posted on 03 Dec 2021
Print article
Illustration
Illustration

A blood test conducted at the time of diagnosis can predict COVID-19 related illness severity and death, according to a new study.

The study conducted by researchers at the Nagourney Cancer Institute (Long Beach, CA, USA) compared 82 patients with RT-PCR confirmed COVID-19 with 31 healthy controls. Blood samples were obtained from each patient and studied for biochemical composition using quantitative mass spectrometry. This technique allowed researchers to measure minute quantities of metabolites in the blood. Investigators identified metabolic signatures that could distinguish mild COVID-19 infection from more severe and lethal forms of the disease.

The implications could be profound as it could enable the healthcare community to stratify patients based on individual risk, allowing doctors to allocate medical resources more effectivity and treat those at greatest risk earlier in the course of the disease before severe complications set in. The findings suggest that it is not the infecting organism, in this case the COVID-19 virus, but instead the individual's response to the infection that determines outcome. This could have important ramifications for the management of newer variants as they arise.

"It has long been recognized that persons with certain co-morbidities such as diabetes, obesity and cardiovascular disease have a higher risk of severe COVID-19 infection," said Dr. Nagourney, lead researcher. "Our results now confirm the metabolic basis of COVID-19 severity. By using amino acid, lipid and other blood measures, we showed that subtle, previously undetectable levels of liver, mitochondrial and immune abnormalities underlie each persons' predisposition to life-threatening COVID-19 infection."

"When we compared the usual risk factors such as obesity against our new metabolic signatures, the biochemical measures proved highly discriminatory and may in the future enable us to find those otherwise healthy, younger patients who are destined to develop more severe disease, all in time to intervene," added Nagourney.

Related Links:
Nagourney Cancer Institute 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Repeater Pipette
CAPPR10 Repeater Pipette

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.